Medicine & Life Sciences
Atrial Fibrillation
24%
Blood Pressure
7%
Brain Natriuretic Peptide
19%
Chronic Renal Insufficiency
21%
Clinical Decision Rules
14%
Cohort Studies
26%
Confidence Intervals
9%
Cost-Benefit Analysis
11%
Costs and Cost Analysis
6%
Creatinine
5%
Cross-Sectional Studies
5%
Delivery of Health Care
12%
Economics
5%
England
24%
General Practice
18%
General Practitioners
10%
Glomerular Filtration Rate
12%
Guidelines
6%
Heart
10%
Heart Failure
100%
Hospitalization
5%
Kidney
11%
Left Ventricular Dysfunction
5%
Meta-Analysis
9%
Mortality
8%
Multimorbidity
6%
National Institutes of Health (U.S.)
9%
Natriuretic Peptides
37%
Obesity
5%
Observational Studies
7%
Organizations
8%
Point-of-Care Systems
6%
Population
8%
Primary Health Care
63%
pro-brain natriuretic peptide (1-76)
9%
Pulmonary Embolism
6%
Quality of Life
9%
Randomized Controlled Trials
6%
Referral and Consultation
6%
Secondary Care
6%
Stroke
11%
Survival
12%
Systematic Reviews
19%
Therapeutics
5%
Thiazolidinediones
5%
Thromboembolism
8%
Transient Ischemic Attack
12%
Treatment Failure
6%
Venous Thrombosis
7%